Half-year report · Q2
3937.TEDINET S100UMD4
Period2024-04-01 → 2024-09-30
Filed2024-11-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥5.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥591m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥541m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥629m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥936m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥467m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥629m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥467m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥443m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥526m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥301m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥443m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥301m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥7.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥6.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥6.4bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.1bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥2.2bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥4.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.4bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.6bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.8bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥651m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥727m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥504m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥39m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥273m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥221m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥57m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥155m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥169m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥36.87 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.73 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.57 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥36.81 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥44.15 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.1 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 70.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥22m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥22m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥190m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥15m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥240m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥847m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥841m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥542m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.1bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥22m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥781m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥22m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥781m |
| Otherother segments | revenue | 2023-04-01 → 2023-09-30 | ¥600,000 |
| Otherother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥600,000 |
| Otherother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥300,000 |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥17m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥170m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥233m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥798m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥798m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥477m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥711m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥711m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 495
| Item | Context | Value | Unit |
|---|---|---|---|
| Software | Prior1YearInstant | 13425000 | JPY |
| Software | CurrentQuarterInstant | 7402000 | JPY |
| Software in progress | Prior1YearInstant | - | JPY |
| Software in progress | CurrentQuarterInstant | 2711000 | JPY |
| Right of use assets ia | Prior1YearInstant | 199795000 | JPY |
| Right of use assets ia | CurrentQuarterInstant | 124338000 | JPY |
| Intangible assets | Prior1YearInstant | 213221000 | JPY |
| Intangible assets | CurrentQuarterInstant | 134452000 | JPY |
| Investment securities | Prior1YearInstant | 421988000 | JPY |
| Investment securities | CurrentQuarterInstant | 415325000 | JPY |
| Investments in capital of subsidiaries and affiliates | Prior1YearInstant | 62939000 | JPY |
| Investments in capital of subsidiaries and affiliates | CurrentQuarterInstant | 61483000 | JPY |
| Deferred tax assets | Prior1YearInstant | 298808000 | JPY |
| Deferred tax assets | CurrentQuarterInstant | 296496000 | JPY |
| Other ioa | Prior1YearInstant | 86334000 | JPY |
| Other ioa | CurrentQuarterInstant | 87719000 | JPY |
| Investments and other assets | Prior1YearInstant | 870071000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 861024000 | JPY |
| Noncurrent assets | Prior1YearInstant | 1223640000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 1116940000 | JPY |
| Assets | Prior1YearInstant | 6883815000 | JPY |
| Assets | CurrentQuarterInstant | 7224296000 | JPY |
| Accounts payable trade | Prior1YearInstant | 121618000 | JPY |
| Accounts payable trade | CurrentQuarterInstant | 139187000 | JPY |
| Short term loans payable | Prior1YearInstant | 100000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 100000000 | JPY |
| Lease obligations cl | Prior1YearInstant | 113389000 | JPY |
| Lease obligations cl | CurrentQuarterInstant | 68355000 | JPY |
| Income taxes payable | Prior1YearInstant | 240646000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 164396000 | JPY |
| Contract liabilities | Prior1YearInstant | 763261000 | JPY |
| Contract liabilities | CurrentQuarterInstant | 844206000 | JPY |
| Provision for bonuses | Prior1YearInstant | 56313000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 137835000 | JPY |
| Other cl | Prior1YearInstant | 330728000 | JPY |
| Other cl | CurrentQuarterInstant | 260081000 | JPY |
| Current liabilities | Prior1YearInstant | 1725958000 | JPY |
| Current liabilities | CurrentQuarterInstant | 1714064000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 75222000 | JPY |
| Lease obligations ncl | CurrentQuarterInstant | 47750000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 180364000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 180100000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 163360000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 130639000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 19115000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 18317000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 438063000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 376808000 | JPY |
| Liabilities | Prior1YearInstant | 2164021000 | JPY |
| Liabilities | CurrentQuarterInstant | 2090872000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |